DrugInfoSys

Betamethasone

Also known as: Betamethasone -17-valerate

Drug #2148

Betamethsone is a synthetic glucocorticoid, the most active of the anti-infalammatory steroids, used topically as an anti-infalmmatory and administered orally as a replacment therapy for adrenal insufficiency.<br>Its derivative Betamethasone Dipropionate is a corticosteroid with mainly glucocorticocoid activity. It has slow but more prolonged actions. Betamethasone Dipropionate is used topically in the treatment of various skin disorders. Betamethasone Sodium Phosphate is a corticosteroid which is used topically or rectally as sodium phosphate as an antiinflammatory steroid. Betamethasone (Valerate) is the 17-valerate ester of betamethasone.

Primary Characteristics

Betamethasone is also known as Betamethasone -17-valerate , Betamethasone (Valerate), Betamethasone Dipropionate, Betamethasone Sodium Phosphate..

It is of Synthetic origin and belongs to Steroid.

It belongs to Glucocorticoid agonist pharmacological group on the basis of mechanism of action and also classified in Corticosteroid Parenteral pharmacological group. It is also classified under Dermatological Products .

Molecular Weight: 392.46 · Solubility in Water: insoluble · Solubility in Alcohol: 1 in 12 · Non-proprietary name: Betamethasone.

Molecular structure of Betamethasone

Pharmacokinetics

Distribution: Betamethasone has a plasma protein binding is 64%.

Elimination: plasma half-life is 5.6 hrs, renal excretion is major.

Advertisement

Indications

Contraindications

Dosage

Betamethasone's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
4 – 20 mgIVAt affected area only .
0.1 %0.1 %Every 4hOticFrequency may be increased upto 12 times/day if needed.
0.5 – 5 mgEvery 24hPO
0.075 %0.075 %Every 8hTopicalAt affected area only .
Paediatric Dosage (20kg)
0.2 mg/kg0.2 mg/kgEvery 8hIV
0.027 mg/kg0.027 mg/kgEvery 12hOral
0.1 %0.1 %Every 8hTopical
Neonatal Dosage (3kg)
No data.

Drug Interactions

2 interactions
Major3 interactions
Minor1 interaction
Moderate3 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Betamethasone in overdosage may give rise to further complications which include Atrophy , Steroid purpura, Angioedema , Skin fragility , Steroid purpura, Perioral dermatitis.

Betamethasone produces potentially life-threatening effects which include Cushing`s syndrome, Diabetes, Hypertension, Growth suppression. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Betamethasone are Electrolyte imbalance , Convulsions , Abdominal distension.

Betamethasone is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Acne, Anxiety, Arthralgia, Cataract, Constipation , Diarrhea, Erythema, Fever, Headache, Hypersensitivity reactions, Hypertrichosis , Hypotension , Local hypopigmentation, Menstrual irregularity, ocular changes, Peptic ulcer, Pigmentation, Skin thinning, Subcutaneous atrophy, Superficial blood vessels dilatation, Superficial blood vessels thinning, Sweating , Vertigo.

Warnings / Precautions

Betamethasone should be used with caution in patients with active tuberculosis infection of respiratory tract or in untreated fungal, bacterial or systemic viral infections. Corticosteroids should only be used systemically with great caution in the presence of congestive heart failure (CHF), recent myocardial infraction (MI), hypertension, diabetes mellitus, epilepsy, glaucoma, hypothyroidism, liver failure, osteoporosis, peptic ulceration or renal impairment. Children may be at increase risk of some adverse effects, corticosteroid causes growth retardation and prolonged use is rarely justified. Passive immunization is recommended to non-immune patients who do come in contact with chickenpox or measles. Live vaccine should not be given to patients receiving high dose systemic corticosteroid therapy nor for atleast 3 months afterwards, killed vaccine or toxoids may be given, although the response may be attenuated. During prolong treatment with corticosteroids, patients should be examined regularly, sodium intake may need to be reduced and calcium and potassium supplement may be necessary. Patient should carry cards given full details of their corticosteroid therapy. Avoid use during pregnancy. Use nasal steroids with caution until healing has occurred.Long-term therapy should be avoided espacially in infants and children as adrenal suppression may occur. Care should be taken so that the prepation does not enter the eyes as glucoma may result. In secondary infected lesions antimicrobial therapy should be used in cases of spread of infection, topical steroid therapy, should be stopped. prolong aaplication on the face should be avoided.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Betamethasone should be stored Inj. Tab, Oint, Gel, Cream, Lotion, Oral Soln.

Drug Classification

  1. 1.13.3.1Corticosteroids plain
  2. 2.18.1Corticosteroids, systemic
  3. 3.21.2.1Corticosteroids
  4. 4.28Otic drugs

Manufacturers